ASHM Testing Portal
The Testing Policies offered by ASHM are specifically designed for healthcare professionals and pathologists who order or conduct HIV, hepatitis C, and hepatitis B tests, as well as those involved in interpreting and delivering the test results to patients. These policies establish a comprehensive framework that ensures high-quality testing while eliminating both real and perceived […]
HCV In Children: Australian Commentary On AASLD-IDSA Guidance
This document provides Australian (AU) Commentary on the AASLD-IDSA HCV Guidance: HCV in Children. Recommendations for testing, managing, and treating hepatitis C. Australian commentary has only been provided where needed in order to provide additional clarification or detail variations found in the Australian setting. Topics cover testing; transmission and prevention; monitoring and medical management; whom […]
Decision Making – Hepatitis C In Children
Last clinical update: March 2024Latest version: December 2024, updated with HepLink Australia details. This two-page summary was developed from the HCV in Children: Australian Commentary on AASLD-IDSA Guidance. The resource supports clinicians to provide advice and manage hepatitis C in children. Page 1 provides recommendations on which tests to order and when testing of babies […]
Australasian Contact Tracing Guidelines
When patients are diagnosed with a treatable sexually transmitted infection, it’s vital to consider, discuss, and support the testing and treatment of their sexual partners. Research shows that many partners may be infected without realising it. That’s why it’s crucial to make partner notification a priority and ensure it’s done successfully. Treating infected partners not […]
A Guide To My Health Record: For BBV & STI Healthcare Providers To Support Their Patients
Interpreting The Liverpool Hep Interactions Checker
This 1-page flow-chart developed by the University of Liverpool in collaboration with ASHM and INHSU outlines simple steps to follow after identifying potential drug-drug interactions involving hepatitis C direct acting antiviral (DAA) regimens. Primary care providers can confidently determine when and how to proceed with DAA treatment after consulting this resource. The drug-drug interactions checker website can […]
Hepatitis C Consensus Statement
The “Australasian recommendations for the management of hepatitis C virus infection: a consensus statement” is provided in an easy-to-navigate web-based format. It is a comprehensive resource that serves as a vital reference for healthcare professionals involved in the management and treatment of chronic hepatitis C virus (HCV) infection. Covering topics such as epidemiology, models of […]
C Me, Hear Me. Hepatitis C In Our Own Words
Hepatitis C is one of the most commonly reported diseases in Australia. There have been, and continue to be, improvements in treatments, although the number of people commencing therapy remains low. The stigma and discrimination associated with hepatitis C creates significant barriers to accessing education, care and support, and treatment services. Launched in 2012, the […]
Beyond The C
Beyond the C is a national partnership program aimed at eliminating hepatitis C by 2030. It collaborates with General Practice to identify individuals living with hepatitis C and connect them with appropriate care. By joining the program, healthcare professionals can improve the quality of care for communities most affected by hepatitis C, align their practice […]
ASHM HCV GP Management Plan March 2021
ASHM HCV GP Management Plan
